Europe — EMA
Oseltamivir Crescent Pharma
Oseltamivir, the active ingredient in Oseltamivir Crescent Pharma, is a neuraminidase inhibitor presented as a 75 mg capsule for oral use.
Request sourcing
What is Oseltamivir?
Oseltamivir, the active ingredient in Oseltamivir Crescent Pharma, is a neuraminidase inhibitor presented as a 75 mg capsule for oral use. It treats influenza A and B infections in adults and children twelve years of age and older.
GNH USA supplies Oseltamivir Crescent Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Oseltamivir used for?
Oseltamivir Crescent Pharma is a neuraminidase inhibitor that reduces viral replication within the influenza virus family.
- Influenza A infection: shortens the duration of symptoms when treatment is started early. - Influenza B infection: shortens the duration of the illness by reducing viral load in the body. - Post‑exposure prophylaxis: helps prevent influenza infection after contact with an infected person or outbreak setting for up to 10 days.
What are the side effects of Oseltamivir?
Oseltamivir is generally well‑tolerated, but some patients experience adverse reactions.
Common Side Effects: - Nausea: N N N N. - Vomiting : V V V V. - Headache : H H H H. - Diarrhea : D D or D D.
Serious or Rare Side Effects: - Neuropsychiatric events : C C C C. - Severe allergic reaction : E E E … - Stevens‑ Stevens Ste … ...
